(Credit: Kyle LaHucik for Endpoints News) July 2, 2026 11:30 AM EDT R&D Revolution Medicines shares promising data around KRAS drug combination Lei Lei Wu News Reporter Revolution Medicines on Thursday gave a first look at the early-stage data that led it to plan a Phase 3 trial combining two KRAS drugs … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
87 words · extracted 19d agoread original ↗
comments(0)
5-min edit window · permanent after that